135 related articles for article (PubMed ID: 1263076)
1. Platinum complexes: a new class of antineoplastic agents.
Leh FK; Wolf W
J Pharm Sci; 1976 Mar; 65(3):315-28. PubMed ID: 1263076
[No Abstract] [Full Text] [Related]
2. New platinum complexes with anti-tumour activity.
Connors TA; Jones M; Ross WC; Braddock PD; Khokhar AR; Tobe ML
Chem Biol Interact; 1972 Nov; 5(6):415-24. PubMed ID: 4652593
[No Abstract] [Full Text] [Related]
3. A proposed mode of action of antitumor platinum compounds based upon studies with cis-dichloro-((G- 3 H)dipyridine)platinum(II).
Howle JA; Gale GR; Smith AB
Biochem Pharmacol; 1972 May; 21(10):1465-75. PubMed ID: 5029426
[No Abstract] [Full Text] [Related]
4. Antileukemic properties of organoplatinum complexes.
Meischen SJ; Gale GR; Lake LM; Frangakis CJ; Rosenblum MG; Walker EM; Atkins LM; Smith AB
J Natl Cancer Inst; 1976 Oct; 57(4):841-5. PubMed ID: 1003531
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.
Miernicka M; Szulawska A; Czyz M; Lorenz IP; Mayer P; Karwowski B; Budzisz E
J Inorg Biochem; 2008 Feb; 102(2):157-65. PubMed ID: 17868889
[TBL] [Abstract][Full Text] [Related]
6. Non platinum metal complexes as anti-cancer drugs.
Ott I; Gust R
Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
[TBL] [Abstract][Full Text] [Related]
7. Platinum compounds in cancer chemotherapy.
Pouskouleli G; Kourounakis P
Biochem Exp Biol; 1980; 16(2):191-212. PubMed ID: 6753877
[No Abstract] [Full Text] [Related]
8. Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity.
Lee K; Tashiro T; Noji M
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):702-3. PubMed ID: 8004720
[TBL] [Abstract][Full Text] [Related]
9. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
Lazarević T; Rilak A; Bugarčić ŽD
Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
[TBL] [Abstract][Full Text] [Related]
10. Antileukemic properties of combinations of radiation and malonato(1,2-diaminocyclohexane) platinum(ii) (NSC-224964).
Morris CR; Blackwell LH; Loveless VS
J Med; 1977; 8(3-4):253-9. PubMed ID: 267715
[TBL] [Abstract][Full Text] [Related]
11. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
Babak MV; Ang WH
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
[TBL] [Abstract][Full Text] [Related]
12. Unique platinum-DNA interactions may lead to more effective platinum-based antitumor drugs.
Komeda S
Metallomics; 2011 Jul; 3(7):650-5. PubMed ID: 21519596
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and tumor inhibiting activity of lanthanum (III) complexes with some 1-aminocycloalkancarboxylic acids.
Kovachev TB; Ivanov DS; Buyukliev RT; Konstantinov SM; Karaivanova MC
Pharmazie; 1996 Jan; 51(1):25-7. PubMed ID: 8999429
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
Keppler BK; Diez A; Seifried V
Arzneimittelforschung; 1985; 35(12):1832-6. PubMed ID: 4096739
[TBL] [Abstract][Full Text] [Related]
15. Bronchogenic carcinoma: new drugs available for study.
Slavik M; Carter SK
Cancer Chemother Rep 3; 1973 Mar; 4(2):265-9. PubMed ID: 4125744
[No Abstract] [Full Text] [Related]
16. A new platinum complex of triazine demonstrates G1 arrest with novel biological profile in human breast cancer cell line, MDA-MB-468.
Mandal S; Bérubé G; Asselin E; Richardson VJ; Church JG; Bridson J; Pham TN; Pramanik SK; Mandal SK
Bioorg Med Chem Lett; 2007 Apr; 17(8):2139-45. PubMed ID: 17321743
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of triazolium-bis(triazole)-tetrachlororuthenate (III) and bistriazolium-triazolepentachlororuthenate (III). Two representatives of a new class of inorganic antitumor agents.
Keppler BK; Balzer W; Seifried V
Arzneimittelforschung; 1987 Jul; 37(7):770-1. PubMed ID: 3675670
[TBL] [Abstract][Full Text] [Related]
18. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: design, synthesis, structure-activity relationships and biological evaluation.
Fortin S; Brasseur K; Morin N; Asselin É; Bérubé G
Eur J Med Chem; 2013 Oct; 68():433-43. PubMed ID: 23994871
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of seleno- and thioguanine-platinum(II) complexes and their antitumor activity in mice.
Maeda M; Abiko N; Sasaki T
J Med Chem; 1981 Feb; 24(2):167-9. PubMed ID: 7205884
[TBL] [Abstract][Full Text] [Related]
20. Antitumor properties of organometallic metallocene complexes of tin and germanium.
Köpf-Maier P; Janiak C; Schumann H
J Cancer Res Clin Oncol; 1988; 114(5):502-6. PubMed ID: 3182909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
